Company Filing History:
Years Active: 1997
Title: Frank Thomas Hartl: Innovator in Folic Acid Conjugates
Introduction
Frank Thomas Hartl is a notable inventor based in Chestnut Ridge, NY (US). He has made significant contributions to the field of biochemistry, particularly in the development of novel conjugates for immunoassays. His work has implications for the detection of folic acid in biological fluids, which is crucial for various medical applications.
Latest Patents
Hartl holds a patent for a folate-alp conjugate. This patent discloses innovative folic acid-alkaline phosphatase conjugates that are useful in competitive immunoassays for folic acid in biological fluids such as serum. A preferred conjugate involves a folate hapten bound to (N-Succinimidyl-4-iodoacetyl-aminobenzoate) through a 1,12-diamino-4,9-dioxadodecanyl spacer arm. This invention showcases his expertise in creating effective diagnostic tools.
Career Highlights
Throughout his career, Hartl has been associated with Bayer Corporation, where he has contributed to various research initiatives. His work has been instrumental in advancing the understanding of folic acid's role in health and disease. His innovative approach has led to the development of practical applications that benefit the medical community.
Collaborations
Hartl has collaborated with esteemed colleagues, including James P. Albarella and Linda M. Anderson-Mauser. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the impact of their research.
Conclusion
Frank Thomas Hartl is a distinguished inventor whose work in folic acid conjugates has made a significant impact in the field of biochemistry. His contributions continue to influence diagnostic methods and improve health outcomes.